EUR/USD: Scope for one final leg higher to 1.1185/1.1275 – Credit Suisse EURUSD Banks
EUR/USD’s rally is clearly slowing but economists at Credit Suisse still see scope for one final leg higher to the 1.1185/1.1275 zone.“EUR/USD uptrend is clearly slowing with strength again essentially capped at the shallow uptrend channel from the beginning of January. We would still though not rule out one final leg higher to our 1.1185/1.1275 core target – the 61.8% retracement and March 2022 high. Our bias would then be to look for an important top here.
“Below support at 1.0963 is now needed to mark a near-term top for a test of the April low and 55-DMA at 1.0806/1.0788, which ideally holds on a closing basis. Below though would warn of a potentially more important downturn and a test of support at 1.0540/1.0483.”Information on these pages contains forward-looking statements that involve risks and uncertainties.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
UBS wary of buying Credit Suisse in February, wanted more analysis - SEC filingUBS said it had concluded in February that buying its stricken rival Credit Suisse was not desirable, but that it should prepare in case the lender encountered 'serious financial difficulties'.
Weiterlesen »
UBS weighed Credit Suisse deal as early as December - SEC filingUBS was considering the potential impact of buying struggling rival Credit Suisse as early as December, months before the takeover was hastily arranged by Swiss authorities in March, according to a regulatory filing.
Weiterlesen »
UBS weighed Credit Suisse deal as early as DecemberUBS was considering the potential impact of buying struggling rival Credit Suisse as early as December, months before the takeover was hastily arranged by Swiss authorities in March, according to a regulatory filing.
Weiterlesen »
Breakingviews - The end of cheap credit could hurry Japanese M&AAstellas Pharma has snapped up U.S. eye-treatment specialist Iveric Bio in a $5.9 billion deal, funded almost entirely with debt. Diversifying abroad looks attractive to many Japanese companies given weak home markets. For the $28 billion drugmaker, which already earns the bulk of its revenue from overseas, exceptionally low borrowing costs at home may have boosted its offshore appetite even more.
Weiterlesen »
Charlie Munger on credit crunch, real estate, tough time for investorsWarren Buffett's business partner warns of a credit crunch in commercial real estate - and says it's a tough time to be an investor
Weiterlesen »
Eslabon Armado’s Pedro Tovar Says He’s ‘Not Receiving Credit’ For Peso Pluma CollabPedro Tovar, Eslabón Armado’s leader and vocalist who wrote the band’s hit “Ella Baila Sola,” expressed his disappointment over Peso Pluma’s solo performance of their song on 'The Tonight Show Starring Jimmy Fallon.'
Weiterlesen »